WO2003077843A3 - Methodes de purification de proteines de la famille de l'antigene carcinoembryonnaire (ace) - Google Patents
Methodes de purification de proteines de la famille de l'antigene carcinoembryonnaire (ace) Download PDFInfo
- Publication number
- WO2003077843A3 WO2003077843A3 PCT/US2003/007051 US0307051W WO03077843A3 WO 2003077843 A3 WO2003077843 A3 WO 2003077843A3 US 0307051 W US0307051 W US 0307051W WO 03077843 A3 WO03077843 A3 WO 03077843A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- family member
- substantially free
- member proteins
- disclosed
- cea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003218007A AU2003218007A1 (en) | 2002-03-13 | 2003-03-06 | Methods for purifying selected cea family member proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/097,447 | 2002-03-13 | ||
US10/097,447 US6949629B2 (en) | 2002-03-13 | 2002-03-13 | Methods for purifying selected CEA family member proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003077843A2 WO2003077843A2 (fr) | 2003-09-25 |
WO2003077843A3 true WO2003077843A3 (fr) | 2006-03-16 |
Family
ID=28039186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/007051 WO2003077843A2 (fr) | 2002-03-13 | 2003-03-06 | Methodes de purification de proteines de la famille de l'antigene carcinoembryonnaire (ace) |
Country Status (3)
Country | Link |
---|---|
US (1) | US6949629B2 (fr) |
AU (1) | AU2003218007A1 (fr) |
WO (1) | WO2003077843A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1417965A1 (fr) * | 2002-11-07 | 2004-05-12 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Molécules capables de se lier à des lectines de type-C, leur identification et usages |
US8541187B2 (en) | 2011-03-01 | 2013-09-24 | Bio Tracking, LLC | Systems and methods for detecting animal pregnancy |
GB201208756D0 (en) * | 2012-05-17 | 2012-07-04 | Medical Res Council | Methods |
CN112014198B (zh) * | 2020-06-09 | 2021-11-09 | 中国科学院生物物理研究所 | 一种用于富集内源性低分子量蛋白和多肽的试剂盒及方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867363A (en) | 1970-06-01 | 1975-02-18 | Hans John Hansen | Carcinoembryonic antigens |
US4180499A (en) | 1971-01-27 | 1979-12-25 | Hoffmann-La Roche Inc. | Carcinoembryonic antigens |
US3956258A (en) | 1972-05-12 | 1976-05-11 | Hoffmann-La Roche Inc. | Carcinoembryonic antigens |
US4086217A (en) | 1976-03-03 | 1978-04-25 | Hoffmann-La Roche Inc. | Carcinoembryonic antigens |
US4145336A (en) | 1976-04-30 | 1979-03-20 | Scripps Clinic And Research Foundation | Carcinoembryonic antigen isomer |
US4140753A (en) | 1976-04-30 | 1979-02-20 | Scripps Clinic & Research Foundation | Diagnostic method and reagent |
US4180556A (en) | 1977-03-09 | 1979-12-25 | Abbott Laboratories | Pretreatment method for carcinoembryonic antigen assay |
US4228236A (en) | 1978-05-15 | 1980-10-14 | Northwestern University | Process of producing carcinoembryonic antigen |
US4272504A (en) | 1978-12-14 | 1981-06-09 | Abbott Laboratories | Antibody adsorbed support method for carcinoembryonic antigen assay |
US4349528A (en) | 1979-11-21 | 1982-09-14 | The Wistar Institute | Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen |
US4299815A (en) | 1980-02-08 | 1981-11-10 | Hoffmann-La Roche Inc. | Carcinoembryonic antigen determination |
US4471057A (en) | 1981-06-30 | 1984-09-11 | The Wistar Institute | Detection of colorectal carcinoma |
US4863853A (en) | 1982-04-21 | 1989-09-05 | Bartos Patent Development And Holding Company Limited | Method of determining the diagnostic value of monitoring serum-CEA-levels in a carcinoma patient undergoing therapy |
JPH0811075B2 (ja) | 1982-06-30 | 1996-02-07 | 雄治 松岡 | 単クローン性抗cea抗体 |
DE3230299A1 (de) | 1982-08-14 | 1984-02-16 | Hoechst Ag, 6230 Frankfurt | Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung |
US4818709A (en) | 1983-01-21 | 1989-04-04 | Primus Frederick J | CEA-family antigens, Anti-CEA antibodies and CEA immunoassay |
DE3485733D1 (de) | 1983-01-21 | 1992-06-25 | Frederick James Primus | Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung. |
IL75994A0 (en) | 1985-08-01 | 1985-12-31 | Israel Inst Biolog Res | Process for the production of a substance for monitoring cancer patients |
US5231009A (en) | 1986-08-13 | 1993-07-27 | Molecular Diagnostics, Inc. | Cdnas coding for members of the carcinoembryonic antigen family |
US6022958A (en) | 1986-08-13 | 2000-02-08 | Bayer Corporation | cDNAs coding for members of the carcinoembryonic antigen family |
US5122599A (en) | 1986-08-13 | 1992-06-16 | Molecular Diagnostics, Inc. | CDNAS coding for members of the carcinoembryonic antigen family |
US5274087A (en) | 1986-08-13 | 1993-12-28 | Molecular Diagnostics, Inc. | cDNA coding for carcinoembryonic antigen (CEA) |
JPH02107189A (ja) | 1988-05-25 | 1990-04-19 | City Of Hope | 癌胎児抗原フラグメント |
US5200316A (en) | 1990-02-15 | 1993-04-06 | Miles Inc. | Immunoassay methods using noncross reactive cea gene family members antibodies |
ATE248924T1 (de) | 1991-05-06 | 2003-09-15 | Us Gov Health & Human Serv | Karcinoembryonale antigen expremierende rekombinante viren und methoden ihrer anwendung |
DE4133791A1 (de) | 1991-10-11 | 1993-04-15 | Behringwerke Ag | Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung |
DE69432926T2 (de) | 1993-02-05 | 2004-05-13 | Epigen, Inc., Wellesley | Humanes carcinoma-antigen (hca), hca antikörper, hca immunoassays, aufzeichnungsmethoden und therapy |
CA2116640A1 (fr) | 1993-03-25 | 1994-09-26 | Alexey Terskikh | Derives de l'antigene carcino-embryonnaire |
WO1995032286A2 (fr) | 1994-05-20 | 1995-11-30 | Microgenesys, Inc. | Antigene immunogene carcinoembryonnaire et procedes d'utilisation et de production de cet antigene |
DE69837896T2 (de) | 1997-10-10 | 2008-02-14 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Peptidagonisten von karzinoembryonalem Antigen (CEA) |
US6013722A (en) * | 1998-01-27 | 2000-01-11 | 3M Innovative Properties Company | Non-whitening emulsion pressure sensitive adhesives |
US6117981A (en) | 1999-06-03 | 2000-09-12 | Cytoclonal Pharmaceutics, Inc. | Hybridomas for lung cancer marker and monoclonal antibodies thereof |
EP1409534A2 (fr) | 1999-09-27 | 2004-04-21 | Gabriele Pecher | Composition pharmaceutique pour assurer le traitement et la prophylaxie de tumeurs chez l'homme, qui expriment l'antigene tumoral mucine et/ou l'antigene carcino-embryonnaire et son utilisation |
EP1090927A1 (fr) | 1999-10-08 | 2001-04-11 | Hinrich Abken | Polypeptide (scFv) pour la détection et l'élimination de cellules porteuses de l'antigène CA19-9 |
WO2001055337A2 (fr) | 2000-01-25 | 2001-08-02 | Hyseq, Inc. | Procedes et substances relatifs a des polypeptides de type antigene carcino-embryonnaire (cea) et a des polynucleotides |
-
2002
- 2002-03-13 US US10/097,447 patent/US6949629B2/en not_active Expired - Fee Related
-
2003
- 2003-03-06 WO PCT/US2003/007051 patent/WO2003077843A2/fr not_active Application Discontinuation
- 2003-03-06 AU AU2003218007A patent/AU2003218007A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
CALBIOCHEM: "Biochemical & Immunochemical Catalog.", 1996, pages: 76 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003218007A1 (en) | 2003-09-29 |
AU2003218007A8 (en) | 2003-09-29 |
US20030176646A1 (en) | 2003-09-18 |
US6949629B2 (en) | 2005-09-27 |
WO2003077843A2 (fr) | 2003-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1659179A3 (fr) | Dérivés antigènes associés aux tumeurs de la famille mage, et séquences d'acides nucléiques codant ces dérivés, utilisés pour la préparation de protéines de fusion et de compositions destinées à la vaccination | |
NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
HUP0002475A2 (hu) | Módosított immunogén pneumolizinkészítmények mint vakcinák | |
AP2001002199A0 (en) | Novel streptococcus antigens | |
IL141868A0 (en) | Novel methods for therapeutic vaccination | |
WO2000076540A3 (fr) | Proteines et vaccins de streptococcus pneumoniae | |
IL144973A0 (en) | A vaccine which provides protective immunity against a bacterial pathogen | |
SI0994728T1 (sl) | Rekombinantna protitelesa, specifična za beta-amiloidne konce, kodirana z DNA ter postopki za njihovo uporabo | |
EP1203817A3 (fr) | Composés et procédés pour l'immunothérapie et le diagnostic de la tuberculose | |
DE69635783D1 (de) | Antigen omp26 aus haemophilus influenzae | |
BR9913446A (pt) | Produtos de aglicona e métodos de uso | |
GB9205704D0 (en) | High molecular weight membrane proteins of non-typeable haemophilus | |
DE69941505D1 (de) | Verfahren zur herstellung rekombinanter, lipid-modifizierter psaa proteine und deren verwendung | |
WO2003000719A8 (fr) | Produit antigenique manifestant plusieurs copies d'un epitope d'un polypeptide formant des depots implique dans des maladies a formation de plaques et procedes d'utilisation correspondants | |
WO2003077843A3 (fr) | Methodes de purification de proteines de la famille de l'antigene carcinoembryonnaire (ace) | |
EP0369816A3 (fr) | Anticorps monoclonaux spécifiques pour la mucine polymorphe épithéliale humaine | |
MXPA03007992A (es) | Composicion farmaceutica de fragmentos f(ab)2 de anticuerpos y un proceso para su preparacion | |
NZ500151A (en) | A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence | |
WO2001034184A3 (fr) | Methodes et compositions de protection contre l'herpesvirus bovin 1 | |
AU3193897A (en) | Vaccine comprising antigens bound to carriers through labile bonds | |
AU7547987A (en) | Method of preparation and use for feline leukemia virus antigens | |
WO2002041921A3 (fr) | Procedes et compositions de protection contre des maladies virales de bovides | |
WO2002012535B1 (fr) | Utilisation d'anticorps anti-ceacam pour la stimulation de cellules b dans la production d'anticorps monoclonaux ou en immunotherapie | |
AU3718784A (en) | Antibodies and antibody containing compositions for inhibiting gingivitis | |
WO1991015582A3 (fr) | Proto-oncogenes gap purifies, sequences de ces proto-oncogenes et utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |